Chapter 11

Commercial Non-Invasive and Invasive Devices for Heart Failure Prediction

A Review

First published: 22 April 2022

Abstract

This chapter briefly reviews the current invasive and non-invasive devices that are commercially available for monitoring the risk and health status of heart failure patients. Recent advancements in sensor technology have made the development of high-performance, low-cost microsensors easier. The chapter discusses various available external devices for monitoring and predicting the risk, hospital readmission, and mortality of heart failure patients. Hypertension is one of the main causes of cardiovascular disease and its associated risks, including death. Body mass index is one of the crucial indirect indicators for heart disease. Bioimpedance analysis estimates the total body fluid and aids in monitoring the fluid levels in the human body. The chapter discusses the available invasive techniques and commercially available invasive devices and sensors. The available invasive devices for remote monitoring of heart failures are classified into right ventricle pressure monitoring, pulmonary artery pressure sensors, left atrial pressure sensors, and intrathoracic impedance monitoring.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.